6.53
前日終値:
$6.39
開ける:
$6.49
24時間の取引高:
16,666
Relative Volume:
0.63
時価総額:
$9.98M
収益:
$22.03M
当期純損益:
$-19.91M
株価収益率:
-0.3527
EPS:
-18.5136
ネットキャッシュフロー:
$-16.84M
1週間 パフォーマンス:
-2.83%
1か月 パフォーマンス:
+8.47%
6か月 パフォーマンス:
-30.40%
1年 パフォーマンス:
-70.26%
Lifeward Ltd Stock (LFWD) Company Profile
Compare LFWD vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
LFWD
Lifeward Ltd
|
6.53 | 9.77M | 22.03M | -19.91M | -16.84M | -18.51 |
|
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-10 | 開始されました | Laidlaw | Buy |
| 2017-04-03 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2016-12-16 | 開始されました | Oppenheimer | Outperform |
| 2016-07-15 | 開始されました | Piper Jaffray | Overweight |
| 2015-05-22 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2015-05-08 | 繰り返されました | Barclays | Equal Weight |
| 2014-10-07 | 開始されました | Barclays | Equal Weight |
すべてを表示
Lifeward Ltd (LFWD) 最新ニュース
Lifeward closes Oramed partnership, secures $10 million funding By Investing.com - Investing.com India
Lifeward Closes Oramed Partnership, Acquires Oratech Pharma - Moomoo
Lifeward Completes Oratech Acquisition and Secures Private Financing - TipRanks
Lifeward closes Oramed partnership, secures $10 million funding - Investing.com
Lifeward (NASDAQ: LFWD) closes Oratech buy with new shares and $10M notes - Stock Titan
Lifeward Successfully Closes on Strategic Partnership with Oramed - GlobeNewswire
Insider Sell: Is Lifeward Ltd affected by consumer sentiment2026 Decliners & Target Return Focused Stock Picks - baoquankhu1.vn
Lifeward shares fall after Q4 results miss expectations - MSN
If You Invested $1,000 in Lifeward Ltd (LFWD) - Stock Titan
Lifeward Faces Nasdaq Audit Committee Compliance Challenge - The Globe and Mail
Aug Levels: Is Lifeward Ltd a speculative investmentQuarterly Market Summary & Weekly High Return Stock Forecasts - baoquankhu1.vn
Lifeward Ltd. Files Form 8-K with SEC – Key Company Information and Filing Details for March 2026 - Minichart
Lifeward Shares Rise 5.1% on Expanded Distribution Deal in UAE and GCC - MSN
Lifeward Received Notice of Noncompliance - TradingView
Audit committee shortfall puts Lifeward (NASDAQ: LFWD) on Nasdaq non-compliance notice - Stock Titan
LFWD Stock: HC Wainwright & Co. Raises Price Target to $10.00 | - GuruFocus
Lifeward stock price target raised to $10 on partnership strength By Investing.com - Investing.com Canada
Risk Report: Will Lifeward Ltd stock hit new highs in YEARPortfolio Update Summary & High Return Trade Guides - baoquankhu1.vn
Lifeward stock price target raised to $10 on partnership strength - Investing.com UK
Lifeward reports net loss of USD 5.3M in Q4 2025 - Medical Buyer
Rewalk Robotics Ltd receives Investment Bank Analyst Rating Update By Investing.com - Investing.com
Lifeward Ltd (LFWD) Q4 2025 Earnings Call Highlights: Strategic Moves and Market Challenges - GuruFocus
Lifeward Ltd. Announces Strategic Expansion, Acquisition of Exoskeleton Technology, and Improved 2025 Financial Results - Minichart
Lifeward Ltd’s 2025 Earnings Call: Revenue Miss, Medicare Pipeline Discrepancies, and Timelines Clash - Bitget
Lifeward 2025 10-K: Revenue $22.0M, Gross Profit $8.4M - TradingView
Lifeward (LFWD) expands neurorehab platform with Oramed deal and Medicare gains - Stock Titan
Lifeward (LFWD) Pursues Growth with New Strategic Partnership - GuruFocus
Lifeward (LFWD) 2025 Financials: Q4 Revenue $5.1M, Annual Loss $19.9MNews and Statistics - IndexBox
Lifeward: Overview of Fourth Quarter Financial Results - Bitget
Lifeward Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Lifeward Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
LFWD: 2025 revenue fell 14%, but ReWalk unit sales rose 22% and gross margin improved - TradingView
Earnings call transcript: Lifeward Q4 2025 earnings reveal significant shortfall - Investing.com
Lifeward posts Q4 revenue $5.1M, FY2025 revenue $22.0M; net loss narrows to $19.9M - TradingView
LFWD: Strategic shift and new partnerships drive innovation, efficiency, and expanded market access - TradingView
Lifeward: Q4 Earnings Snapshot - WWLTV.com
Oramed deal reshapes Lifeward (NASDAQ: LFWD) with new tech and funding - Stock Titan
Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Press Release: Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results - 富途牛牛
Lifeward Q4 2025 Earnings Call Transcript - MarketBeat
Geopolitics Watch: Is Lifeward Ltd forming bullish engulfing patterns2026 Market WrapUp & AI Powered Market Trend Analysis - baoquankhu1.vn
Lifeward Ltd (LFWD) Q4 2025: Everything You Need To Know Ahead O - GuruFocus
Short Covering: Can Lifeward Ltd maintain sales growth2026 Intraday Action & Weekly Sector Rotation Insights - baoquankhu1.vn
Lifeward Ltd. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Lifeward regains Nasdaq minimum bid price compliance By Investing.com - Investing.com Nigeria
Lifeward Shareholders Approve Oratech Deal and Governance Changes - The Globe and Mail
Lifeward shareholders approve Oramed partnership deal By Investing.com - Investing.com India
LFWD SEC FilingsLifeward Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Lifeward shareholders approve Oratech acquisition and board changes By Investing.com - Investing.com South Africa
Lifeward shareholders approve Oratech acquisition and board changes - Investing.com Nigeria
Lifeward Ltd (LFWD) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):